Skip to content

Professional Updates & Events

News from Recent Conferences, Public Speaking, and Global Medical Leadership

Recently

Proud to present a poster at @ACRheum's ACR Convergence 2026 in Orlando (Nov. 6–11) on patient perspectives on osteoporosis risk measurement from chest X-rays using AI.

• Date: November 6th-11th, 2026

Dr. Silverman is directing an international study on patient perspectives on use of artificial intelligence to measure osteoporosis fracture risk from routine chest x-rays.

Dr Silverman has successfully used a peptide BPC157/TB500 to treat hand/thumb osteoarthritis.

• Date: August 27th, 2026 

------


Dr. Silverman successfully treated a patient with midfoot osteoarthritis using targeted BPC-157 joint injections. The patient, who could not walk and was unable to tolerate cortisone, regained walking mobility with minimal pain and swelling.
• Date: August 5th, 2026 

------

Dr. Silverman is lecturing on osteoporosis to the Cedars Sinai rheumatology fellows.
• Date: June 5, 2026 

------

Dr. Silverman has been invited to participate in an advisory board on Biosimilars in Osteoporosis in Chicago

• Date: June 3, 2026 


------

Dr. Silverman has been invited to join a WHO bone experts working group.

------

International Osteoporosis Foundation (IOF) World Congress

• Date: May 8, 2026

• Location: Prague, Czech Republic
• Engagement: Dr. Silverman participated in the International Osteoporosis Foundation (IOF) World Congress.

 

------


Global Clinical Participation & Academic Publication

 
• Date: March 2026
• Engagement: Participation in the International Mastocytosis Congress, collaborating with global experts on the latest diagnostic and treatment protocols for mast cell disorders.
• Publication: Dr. Silverman has published a new clinical chapter investigating the intersection of climate change and rheumatic disease, exploring how environmental shifts impact systemic inflammation and patient health.
• Focus: Bridging the gap between environmental health and advanced rheumatology to improve long-term patient outcomes.


------

Clinical Research Milestone: Top 5% Globally for Citations
 
• Date: March 2026
• Achievement: Dr. Silverman has surpassed 13,375 citations of his published medical research, placing him in the top 5% of the global Doximity medical community.
• Impact: This milestone reflects the profound influence of Dr. Silverman’s work on global clinical standards, particularly in the fields of osteoporosis diagnosis, fracture risk prediction, and bone turnover markers.
• Academic Standing: With an H-index of 54, his research continues to be a primary reference for leading medical journals, including The New England Journal of Medicine, The Lancet, and JAMA.

------

California Neurologic Society Presentation

• Date: November 7, 2025
• Location: Berkeley, CA
• Subject: Expert presentation on the latest developments in Fibromyalgia management to the California Neurologic Society.

Explore All Of Our Services

To provide you with the most comprehensive care, we offer specialized evaluation and management across these core clinical areas. Select a service below to learn more about our professional approach in Beverly Hills, CA.

Click on a service to learn more.

• Osteoporosis • Fibromyalgia • Chronic Fatigue & Long Haul COVID • Mast Cell Activation (MCAS) • Osteoarthritis • Lipomatosis (Dercum’s Disease) • Peptide Therapy (BPC-157) for Osteoarthritis
TAKE CONTROL OF YOUR HEALTH

Contact Us Today for Your Consultation

Experience the difference that 40 years of world-class expertise can make in your health. Call our Beverly Hills, CA office at 310-358-2234 to request your consultation.
Contact Us